You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藍帆醫療(002382.SZ)擬向NVT HK分期出資8000萬美元及分期出資5.76億元持有海納睿信48%合夥企業份額
格隆匯 12-04 21:11

格隆匯 12 月 4日丨藍帆醫療(002382.SZ)公佈,2020年12月4日,公司第五屆董事會第十次會議審議並通過了《關於對相關主體進行出資的議案》。

公司的全資子公司BluesailNew Valve Technology HK Limited(“NVT HK”)主營業務為投資控股、商務諮詢和國際貿易。基於NVT HK日常運營的需要,公司擬向NVT HK分期出資8000萬美元。

公司與中軒投資有限公司、淄博海納博睿投資管理有限公司投資設立了海納睿信(淄博)醫療投資合夥企業(有限合夥)(“海納睿信”)。公司作為有限合夥人擬分期出資5.76億元持有海納睿信48%的合夥企業份額,中軒投資有限公司作為有限合夥人擬出資6.12億元持有海納睿信51%合夥企業份額,淄博海納博睿投資管理有限公司作為普通合夥人擬出資1200萬元持有海納睿信1%合夥企業份額。此次投資完成後,公司的合併報表範圍不會發生變化。

公司對NVT HK履行出資義務,是為相關主體提供運營資金,推動結構性心臟病治療器械相關業務發展;對海納睿信進行出資,是在公司戰略方向下孵化優質投資項目、儲備優質併購標的,加快公司醫療器械主業發展的步伐。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account